San Diego, CA, United States of America

Robert J Haselbeck

This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Persephone Biosciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert J Haselbeck. Retrieved from https://idiyas.com/inventor/robert-j-haselbeck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Robert J Haselbeck: Innovator in Gut Microflora Modulation

Introduction: Robert J Haselbeck is an inventor based in San Diego, CA (US). He is currently associated with Persephone Biosciences, Inc., where he focuses on innovative solutions for health-related challenges. Despite having no granted patents, his work is significant in the field of microbiome research.

Latest Patent Applications: Robert J Haselbeck has filed several patent applications, including "Compositions for Modulating Gut Microflora Populations, Enhancing Drug Potency and Treating Viral Infections, and Methods for Making and Using Same." This application provides compositions and methods that utilize combinations of non-pathogenic, live bacteria and/or bacterial spores to control and treat diseases, such as viral infections like COVID-19. Another application, "Compositions for Modulating Gut Microflora Populations, Enhancing Drug Potency and Treating Cancer, and Methods for Making and Using Same," outlines similar methodologies for cancer treatment, emphasizing the modulation of gut microbial populations to enhance the effectiveness of various cancer therapies.

Conclusion: Robert J Haselbeck is making strides in the field of gut microbiome research, with a focus on enhancing drug efficacy through innovative compositions. His contributions are poised to impact the treatment of viral infections and cancer significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…